HDAC-3 overexpression has been found to correlate with shorter survival rates in gastric [40], hepatocellular carcinoma [33,46] and glioblastoma [31], whereas it has been associated with prolonged survival in primary and stage IV metastatic melanoma cases [48]. The gene discussed is HDAC3; the disease is glioblastoma.